Hemerion Therapeutics
A new player committed to tackle #glioblastoma and #brain #cancer
France
15 employees
Grant
Total: $8.37M
Health Care
General Information
Get notified when Hemerion Therapeutics moves
Funding, new markets, leadership changes, hiring surges — one e-mail, only when something happens.
Track Hemerion Therapeutics
Get real-time alerts for funding, hiring, news, and 40+ signal types.
See how it worksDiscover More
France Market
Health Care
About Hemerion Therapeutics
Taxonomy: HealthTech, Clinical Stage, Innovative Cancer Treatments, Brain Cancer Research, Glioblastoma Treatment, Academic Research Collaboration, Disruptive Technology, University Partnership, Frontline Approach, Clinical Research, Innovative Therapies, Medical Technology, Cancer Treatment Innovation
Services & Products
Target Customers
Funding Rounds & Investors (5)
View All| Funding Stage | Amount | Investors | Lead Investors | Date |
|---|---|---|---|---|
| Series A | •••••• | 3 |
|
22 May 2025 |
| Equity Crowdfunding | •••••• | - | 15 Jul 2024 | |
| Seed Round | •••••• | 1 |
|
12 Apr 2023 |
| Seed Round | •••••• | 3 |
|
14 Apr 2022 |
| Non Equity Assistance | •••••• | 1 | •••• •••• | 01 Jan 2020 |
Hemerion Therapeutics Alternatives & Competitors
Power and precision in cancer radiotherapeutics.
Patient-forward: Aspiring to make a difference in cancer
Creating Innovative and New Technologies to End Cancer
FAQ About Hemerion Therapeutics
Don't just browse. Track.
Signal Tracker monitors Hemerion Therapeutics and millions of companies for funding rounds, hiring surges, product changes, and 40+ signal types — so you never miss an opportunity.
